Akebia Therapeutics, Inc. - COM (AKBA)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
56.2M
Holdings value Q2 2024
$57.3M
Value change Q2 2024
-$2.53M
Grand Portfolio weight change Q2 2024
0%
Number of holders
99
Number of buys Q2 2024
50
Number of sells Q2 2024
-53
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 72K $95K +$51.2K $1.32 1
2024 Q2 56.2M $57.3M -$2.53M $1.02 100
2024 Q1 57M $104M +$2.03M $1.83 114
2023 Q4 54.6M $67.8M +$4.5M $1.24 84
2023 Q3 50.8M $57.9M +$685K $1.14 74
2023 Q2 50.2M $46M -$1.39M $0.92 75
2023 Q1 51.8M $29M -$98.5K $0.56 63
2022 Q4 52.3M $30.1M +$767K $0.58 69
2022 Q3 52.2M $16.5M -$1.7M $0.32 79
2022 Q2 57.1M $20.2M -$11.2M $0.35 80
2022 Q1 81.2M $58.3M -$32.8M $0.72 121
2021 Q4 96.8M $219M -$4.4M $2.26 127
2021 Q3 97.9M $282M -$32.5M $2.88 117
2021 Q2 106M $400M +$22.2M $3.79 130
2021 Q1 99.9M $338M -$8.61M $3.38 132
2020 Q4 103M $287M -$2.38M $2.80 132
2020 Q3 99.5M $250M -$415M $2.51 154
2020 Q2 111M $1.51B +$263M $13.58 183
2020 Q1 92.2M $699M +$65M $7.58 149
2019 Q4 83.7M $529M -$9.57M $6.32 145
2019 Q3 84.7M $332M -$7.13M $3.92 142
2019 Q2 86.4M $418M -$5.53M $4.84 143
2019 Q1 84.2M $689M +$34.2M $8.19 167
2018 Q4 80.5M $445M +$212M $5.53 153
2018 Q3 40.8M $360M -$30.3M $8.83 126
2018 Q2 42.4M $423M -$5.78M $9.98 136
2018 Q1 43.1M $412M +$81M $9.53 145
2017 Q4 33.7M $501M +$17M $14.87 128
2017 Q3 29.9M $588M +$66.4M $19.67 115
2017 Q2 27.3M $392M +$102M $14.37 115
2017 Q1 20.8M $191M +$23.3M $9.20 85
2016 Q4 20.2M $210M -$1.1M $10.41 91
2016 Q3 19.2M $174M -$411K $9.05 82
2016 Q2 19.6M $147M -$12.7M $7.48 90
2016 Q1 21.1M $191M +$34.4M $9.01 90
2015 Q4 16.3M $209M +$19.7M $12.92 89
2015 Q3 15.1M $146M +$23.2M $9.66 81
2015 Q2 12.2M $126M +$52.4M $10.29 69
2015 Q1 7.02M $77.1M -$2.02M $11.11 59
2014 Q4 7.12M $82.8M -$6.65M $11.64 55
2014 Q3 7.57M $170M +$8.04M $22.13 50
2014 Q2 7.18M $200M +$197M $27.79 50
2014 Q1 104K $2.03M +$2.03M $19.56 3